We need much much MOAR
Marketing must be aimed at a wider audience of new investors
Most existing SHs are already believers, so we need less convincing - but, lots of new investors may not even be aware of Mesoblast
I'm expecting much more marketing activities next year, with product approval, commercialised product, read-outs, partnerships etc - so many facets to shout out - loud & proud
Ann: DMC Completes Final Review of Phase 3 Heart Failure Trial, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.28 |
Change
-0.030(1.30%) |
Mkt cap ! $2.918B | |||
| Open | High | Low | Value | Volume |
| $2.32 | $2.39 | $2.24 | $13.10M | 5.680M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 44474 | $2.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.29 | 30176 | 3 |
View Market Depth
| Last trade - 16.17pm 22/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |